Given the complex interplay among different metabolic pathways, AR responsiveness, AR signaling status, PC types and stages, it will be necessary to characterize PC metabolome in large sample cohorts to verify and validate potential miRNAs involved in metabolic shifts during CRPC development. This evidence concerns the gene AR and pachyonychia congenita.